Rapt Therapeutics Stock Price on August 1, 2024
| RAPT Stock | USD 1.81 0.08 4.62% |
Below is the normalized historical share price chart for RAPT Therapeutics extending back to October 31, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of RAPT Therapeutics stands at 1.81, as last reported on the 27th of December, with the highest price reaching 2.09 and the lowest price hitting 1.72 during the day.
If you're considering investing in RAPT Stock, it is important to understand the factors that can impact its price. RAPT Therapeutics appears to be risky, given 3 months investment horizon. RAPT Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0505, which implies the company had a 0.0505% return per unit of standard deviation over the last 3 months. By inspecting RAPT Therapeutics' technical indicators, you can evaluate if the expected return of 0.84% is justified by implied risk. Please evaluate RAPT Therapeutics' Coefficient Of Variation of 1619.06, market risk adjusted performance of 0.2791, and Mean Deviation of 7.71 to confirm if our risk estimates are consistent with your expectations.
At this time, RAPT Therapeutics' Sale Purchase Of Stock is comparatively stable compared to the past year. Stock Based Compensation is likely to gain to about 17.9 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 27.7 M in 2024. . At this time, RAPT Therapeutics' Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 6.80 in 2024, whereas Price Earnings To Growth Ratio is likely to drop (0.41) in 2024. RAPT Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 31st of October 2019 | 200 Day MA 3.6546 | 50 Day MA 1.5149 | Beta 0.324 |
RAPT |
Sharpe Ratio = 0.0505
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | RAPT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 16.55 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.84 actual daily | 16 84% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average RAPT Therapeutics is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of RAPT Therapeutics by adding it to a well-diversified portfolio.
Price Book 0.6625 | Enterprise Value Ebitda (10.73) | Price Sales 411.2189 | Shares Float 31.6 M | Wall Street Target Price 6 |
Related Headline
Arvinas Headline on 1st of August 2024
Arvinas, Inc. Reported Earnings Last Week And Analysts Are A... by finance.yahoo.com
As you might know, Arvinas, Inc. just kicked off its latest second-quarter results with some very...
RAPT Therapeutics Valuation on August 1, 2024
It is possible to determine the worth of RAPT Therapeutics on a given historical date. On August 1, 2024 RAPT was worth 3.13 at the beginning of the trading date compared to the closed value of 3.12. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of RAPT Therapeutics stock. Still, in general, we apply an absolute valuation method to find RAPT Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of RAPT Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against RAPT Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 3.08 | 3.31 | 3.04 | 3.14 | 257,144 | |
08/01/2024 | 3.13 | 3.20 | 3.01 | 3.12 | 248,157 |
| 2.99 | 3.04 | 2.95 | 2.96 | 315,011 |
| Backtest RAPT Therapeutics | | | RAPT Therapeutics History | | | RAPT Therapeutics Valuation | Previous | Next |
RAPT Therapeutics Trading Date Momentum on August 1, 2024
| On August 02 2024 RAPT Therapeutics was traded for 2.96 at the closing time. The top price for the day was 3.04 and the lowest listed price was 2.95 . The trading volume for the day was 315 K. The trading history from August 2, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 5.13% . The trading delta at closing time against the current closing price is 27.56% . |
RAPT Therapeutics Fundamentals Correlations and Trends
By evaluating RAPT Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among RAPT Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. RAPT financial account trend analysis is a perfect complement when working with valuation or volatility modules.About RAPT Therapeutics Stock history
RAPT Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for RAPT is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in RAPT Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing RAPT Therapeutics stock prices may prove useful in developing a viable investing in RAPT Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 38.3 M | 27.7 M | |
| Net Loss | -75.5 M | -79.2 M |
RAPT Therapeutics Quarterly Net Working Capital |
|
RAPT Therapeutics Stock Technical Analysis
RAPT Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
RAPT Therapeutics Period Price Range
Low | December 27, 2024
| High |
0.00 | 0.00 |
RAPT Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
RAPT Therapeutics December 27, 2024 Market Strength
Market strength indicators help investors to evaluate how RAPT Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading RAPT Therapeutics shares will generate the highest return on investment. By undertsting and applying RAPT Therapeutics stock market strength indicators, traders can identify RAPT Therapeutics entry and exit signals to maximize returns
RAPT Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for RAPT Therapeutics' price direction in advance. Along with the technical and fundamental analysis of RAPT Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of RAPT to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0585 | |||
| Jensen Alpha | 0.824 | |||
| Total Risk Alpha | 0.1067 | |||
| Sortino Ratio | 0.0911 | |||
| Treynor Ratio | 0.2691 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for RAPT Stock Analysis
When running RAPT Therapeutics' price analysis, check to measure RAPT Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RAPT Therapeutics is operating at the current time. Most of RAPT Therapeutics' value examination focuses on studying past and present price action to predict the probability of RAPT Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RAPT Therapeutics' price. Additionally, you may evaluate how the addition of RAPT Therapeutics to your portfolios can decrease your overall portfolio volatility.